Post by PatientView

𝗪𝗵𝗮𝘁 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗦𝗮𝘆, 𝟮𝟬𝟮𝟱-𝟮𝟬𝟮𝟲: 𝗤&𝗔 𝗦𝗲𝗿𝗶𝗲𝘀 In the ‘𝗪𝗵𝗮𝘁 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗦𝗮𝘆, 𝟮𝟬𝟮𝟱-𝟮𝟬𝟮𝟲’ report, PatientView asked pharma companies five questions on how they address R&D demands from patient groups.  Over a series of posts, we’ll be focusing on each of these five questions, highlighting key quotes from pharma companies.  The first we’re focusing on is “𝗛𝗼𝘄 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗮𝘁 𝗶𝗻𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗴𝗿𝗼𝘂𝗽𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗼𝘂𝘁 𝘁𝗵𝗲 𝗥&𝗗 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗲𝘀—𝗳𝗿𝗼𝗺 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝘂𝗻𝗺𝗲𝘁 𝗻𝗲𝗲𝗱𝘀, 𝗼𝗻𝘄𝗮𝗿𝗱𝘀?”   Scroll through the carousel to see quotes from the respondent pharma companies: Boehringer Ingelheim, Novartis, ViiV Healthcare, Servier To access the full ‘What Companies Say, 2025-2026’ report, visit: h͟t͟t͟p͟s͟:͟/͟/͟w͟w͟w͟.͟p͟a͟t͟i͟e͟n͟t͟-͟v͟i͟e͟w͟.͟c͟o͟m͟/͟w͟p͟-͟c͟o͟n͟t͟e͟n͟t͟/͟u͟p͟l͟o͟a͟d͟s͟/͟2͟0͟2͟6͟/͟0͟4͟/͟W͟H͟A͟T͟_͟C͟O͟M͟P͟A͟N͟I͟E͟S͟_͟S͟A͟Y͟_͟2͟0͟2͟6͟_͟0͟8͟.͟p͟d͟f͟